Literature DB >> 15772740

Proton magnetic resonance spectroscopy of normal appearing white matter in familial and sporadic multiple sclerosis.

Małgorzata Siger-Zajdel1, Krzysztof W Selmaj.   

Abstract

OBJECTIVE: To assess metabolite levels in normal-appearing white matter in sporadic and familial multiple sclerosis (MS).
METHODS: Using H-MRS and applying one voxel measure we assessed NAA/Cho, NAA/Cr and Cho/Cr ratios in 26 patients with sporadic and in 25 with familial MS and compared them with healthy subjects.
RESULTS: In both MS groups NAA/Cho and NAA/Cr ratio were significantly lower than in healthy individuals whereas Cho/Cr ratio was higher in MS patients. In sporadic MS patients NAA/Cho and NAA/Cr ratios were lower, although not significantly, than in familial cases. The Cho/Cr ratio was similar in both MS groups.
CONCLUSION: These results suggest that subtle differences in H-MRS measures corresponding to axonal rather than to myelin pathology might occur in sporadic and familial MS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15772740     DOI: 10.1007/s00415-005-0754-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  14 in total

1.  A comparison of sporadic and familial multiple sclerosis.

Authors:  B G Weinshenker; D Bulman; W Carriere; J Baskerville; G C Ebers
Journal:  Neurology       Date:  1990-09       Impact factor: 9.910

2.  Magnetisation transfer ratio analysis of normal appearing white matter in patients with familial and sporadic multiple sclerosis.

Authors:  M Siger-Zajdel; K Selmaj
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-12       Impact factor: 10.154

3.  British Isles survey of multiple sclerosis in twins: MRI.

Authors:  J W Thorpe; C J Mumford; D A Compston; B E Kendall; D G MacManus; W I McDonald; D H Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-04       Impact factor: 10.154

4.  Familial multiple sclerosis: volumetric assessment in clinically symptomatic and asymptomatic individuals.

Authors:  J C Fulton; R I Grossman; L J Mannon; J Udupa; D L Kolson
Journal:  Mult Scler       Date:  1999-04       Impact factor: 6.312

5.  Pathologic damage in MS assessed by diffusion-weighted and magnetization transfer MRI.

Authors:  M Cercignani; G Iannucci; M A Rocca; G Comi; M A Horsfield; M Filippi
Journal:  Neurology       Date:  2000-03-14       Impact factor: 9.910

6.  Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo.

Authors:  S D Wolff; R S Balaban
Journal:  Magn Reson Med       Date:  1989-04       Impact factor: 4.668

7.  Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging.

Authors:  C A Husted; D S Goodin; J W Hugg; A A Maudsley; J S Tsuruda; S H de Bie; G Fein; G B Matson; M W Weiner
Journal:  Ann Neurol       Date:  1994-08       Impact factor: 10.422

8.  Precise relaxation time measurements of normal-appearing white matter in inflammatory central nervous system disease.

Authors:  D H Miller; G Johnson; P S Tofts; D MacManus; W I McDonald
Journal:  Magn Reson Med       Date:  1989-09       Impact factor: 4.668

9.  Correlation of spectroscopy and magnetization transfer imaging in the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosis.

Authors:  J F Hiehle; R E Lenkinski; R I Grossman; V Dousset; K N Ramer; M D Schnall; J A Cohen; F Gonzalez-Scarano
Journal:  Magn Reson Med       Date:  1994-09       Impact factor: 4.668

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  3 in total

1.  Prevalence of radiologically isolated syndrome and white matter signal abnormalities in healthy relatives of patients with multiple sclerosis.

Authors:  T Gabelic; D P Ramasamy; B Weinstock-Guttman; J Hagemeier; C Kennedy; R Melia; D Hojnacki; M Ramanathan; R Zivadinov
Journal:  AJNR Am J Neuroradiol       Date:  2013-07-25       Impact factor: 3.825

2.  A novel unbiased proteomic approach to detect the reactivity of cerebrospinal fluid in neurological diseases.

Authors:  Krishnakumar N Menon; David L Steer; Martin Short; Steven Petratos; Ian Smith; Claude C A Bernard
Journal:  Mol Cell Proteomics       Date:  2011-03-18       Impact factor: 5.911

Review 3.  Quantifying the Metabolic Signature of Multiple Sclerosis by in vivo Proton Magnetic Resonance Spectroscopy: Current Challenges and Future Outlook in the Translation From Proton Signal to Diagnostic Biomarker.

Authors:  Kelley M Swanberg; Karl Landheer; David Pitt; Christoph Juchem
Journal:  Front Neurol       Date:  2019-11-15       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.